| Sarah Anne Selig, OTR | |
|
149 Sylvan St, Danvers, MA 01923-3564 | |
| (978) 774-7570 | |
| Not Available |
| Full Name | Sarah Anne Selig |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 149 Sylvan St, Danvers, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427694025 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 13396 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sarah Anne Selig, OTR 28 Garden St, West Newbury, MA 01985-1712 Ph: (978) 697-7249 | Sarah Anne Selig, OTR 149 Sylvan St, Danvers, MA 01923-3564 Ph: (978) 774-7570 |
News Archive
Herceptin has been touted as a wonder drug for women with HER2-positive breast cancer, an aggressive form of the disease that is fueled by excess production of the HER2 protein. However, not all of these patients respond to the drug, and many who do respond eventually acquire resistance.
Abnormal formation and growth of the placenta is considered an underlying cause of various pregnancy complications such as miscarriages, preeclampsia and fetal growth restriction.
Navigenics, a leading personal genomics company, announced today that the company has raised approximately $18 million of funding. The Procter and Gamble Company, with a worldwide portfolio of leading consumer brands, has joined existing Navigenics investors Kleiner Perkins Caufield and Byers and Mohr Davidow Ventures who also participated in this financing round.
Lineagen, Inc., a developer of innovative genomic tests and services for the screening, evaluation and diagnosis of complex disorders and diseases including autism spectrum disorders and others, today announced that PrairieGold Venture Partners has joined Lineagen's existing institutional venture investors in a further $5 million closing of its Series A round, which completes Lineagen's $10.8 million Series A financing.
Evidence shows that early detection and treatment of cancer can significantly improve health outcomes, however women in Mississippi, particularly in underserved populations, experience the worst health outcomes for cervical, breast, and oropharyngeal cancer.
› Verified 1 days ago
Mrs. Amy Katherine Wyllie, MOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 14 Williams St Apt B10, Danvers, MA 01923 Phone: 774-279-4097 | |
Mrs. Katlyn A. Parsons, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 27 Garden St, Danvers, MA 01923 Phone: 978-777-1122 | |
Beverly Iwanicki, MSCASOTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6 Crane St, Danvers, MA 01923 Phone: 197-877-7853 | |
Marion L Gagnon, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 22 Chase St, Danvers, MA 01923 Phone: 978-774-7833 | |
Marissa Mah, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 63 Locust St, Danvers, MA 01923 Phone: 978-777-0011 | |
Adrienne Michele Donato, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 63 Locust St, Danvers, MA 01923 Phone: 978-762-0536 | |
Gary Wiemann, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 90 Lindall St, Danvers, MA 01923 Phone: 978-777-3740 |